Formoterol dry-powder inhalation - Chemo Iberica/IPASAlternative Names: Eformoterol dry-powder inhalation - Chemo Iberica/IPAS; Formoterol fumarate dry-powder inhalation - Chemo Iberica/IPAS
Latest Information Update: 23 Jul 2007
At a glance
- Originator Chemo Iberica; IPAS
- Mechanism of Action Beta 2 adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 12 Nov 1999 Investigation in Asthma in Italy (Inhalation)
- 12 Nov 1999 Investigation in Asthma in Switzerland (Inhalation)